Citation: Ciaranello AL, Lockman S, Freedberg KA, Hughes M, Chu J, Currier J, Wood R,Holmes CB, Pillay S, Conradie F, McIntyre J, Losina E, Walensky RP;CEPAC-International and OCTANE Investigators. First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: A cost-effectiveness analysis of the OCTANE trial. AIDS. 2011 Feb 20.
Authors
April Kimmel
Assistant Professor Virginia Commonwealth University